Longboard Pharmaceuticals, Inc., (LBPH) Social Stream
LONGBOARD PHARMACEUTICALS INC (LBPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LBPH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $37 | $27 | $31.5 | $23.5 | 34.04% |
| 2022-02-14 | 5 | $37 | $14 | $28.25 | $23.5 | 20.21% |
| 2022-04-01 | 3 | $17.001 | $14 | $15.5 | $23.5 | -34.04% |
| 2022-04-27 | 3 | $25 | $14 | $18.667 | $23.5 | -20.57% |
| 2022-05-06 | 3 | $25 | $14 | $20 | $23.5 | -14.89% |
| 2022-08-10 | 3 | $25 | $12 | $19.333 | $23.5 | -17.73% |
| 2022-11-08 | 3 | $25 | $11 | $19 | $23.5 | -19.15% |
| 2022-11-11 | 4 | $25 | $11 | $18.25 | $23.5 | -22.34% |
| 2023-02-15 | 3 | $25 | $11 | $15.75 | $23.5 | -32.98% |
| 2023-03-03 | 4 | $25 | $11 | $15.75 | $23.5 | -32.98% |
| 2023-03-15 | 5 | $25 | $11 | $16 | $23.5 | -31.91% |
| 2023-05-12 | 6 | $25 | $11 | $15.5 | $23.5 | -34.04% |
| 2023-10-12 | 5 | $25 | $11 | $16.4 | $23.5 | -30.21% |
| 2023-11-07 | 6 | $35 | $11 | $19.5 | $23.5 | -17.02% |
The Trend in the Analyst Price Target
LBPH's average price target has moved down $12.75 over the prior 31 months.
LBPH reports an average of 195.74% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-12 | 6 | 25 | 11 | 15.500 | 8.72 | 77.75% |
| 2023-07-11 | 6 | 25 | 11 | 16.333 | 7.33 | 122.82% |
| 2023-11-06 | 6 | 35 | 11 | 19.500 | 5.24 | 272.14% |
| 2023-11-07 | 6 | 35 | 11 | 19.500 | 5.38 | 262.45% |
| 2023-11-07 | 5 | 35 | 11 | 20.000 | 5.38 | 271.75% |
LBPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 52 weeks, LBPH's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how LONGBOARD PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 378.07% of that group.
- In terms of how LONGBOARD PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 360.11% of that group.
- LONGBOARD PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1594.44% of stocks in the micro market cap category.
- LONGBOARD PHARMACEUTICALS INC's average analyst price target is greater than 1656.43% of stocks in the micro market cap category.
Stocks similar to LONGBOARD PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RPHM, ANEB, and ACXP.
View All Top Stocks by Price Target
What is the outlook for LBPH? Use POWR Ratings for clearer insight into price direction.